Cargando…
Aspirin as secondary prevention in colorectal cancer liver metastasis (ASAC trial): study protocol for a multicentre randomized placebo-controlled trial
BACKGROUND: Colorectal cancer is one the most common cancers in the western world with increasing incidence. Approximately 50% of the patients develop liver metastases. Resection of liver metastases is the treatment of choice although almost half of the resected patients get recurrence in the liver....
Autores principales: | Yaqub, Sheraz, Bjørnbeth, Bjørn Atle, Angelsen, Jon-Helge, Fristrup, Claus Wilki, Grønbech, Jon Erik, Hemmingsson, Oskar, Isaksson, Bengt, Juel, Ingebjørg Soterud, Larsen, Peter Nørgaard, Lindell, Gert, Mortensen, Frank Viborg, Mortensen, Kim Erlend, Rizell, Magnus, Sandström, Per, Sandvik, Oddvar Mathias, Sparrelid, Ernesto, Taflin, Helena, Taskén, Kjetil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451095/ https://www.ncbi.nlm.nih.gov/pubmed/34544470 http://dx.doi.org/10.1186/s13063-021-05587-w |
Ejemplares similares
-
Urban versus rural residency and pancreatic cancer survival: A Danish nationwide population-based cohort study
por: Kirkegård, Jakob, et al.
Publicado: (2018) -
Future Liver Remnant (FLR) Increase in Patients with Colorectal Liver Metastases Is Highest the First Week After Portal Vein Occlusion: FLR Increase in Patients with CRLM Is Highest the First Week After PVO
por: Hasselgren, Kristina, et al.
Publicado: (2018) -
Prospective, single-center implementation and response evaluation of pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis
por: Graversen, Martin, et al.
Publicado: (2018) -
ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis: Results From a Scandinavian Multicenter Randomized Controlled Trial (LIGRO Trial)
por: Sandström, Per, et al.
Publicado: (2018) -
Treatment patterns and survival in patients with hepatocellular carcinoma in the Swedish national registry SweLiv
por: Henriksson, M., et al.
Publicado: (2019)